The first total synthesis of extracellular factor, ''Avenolide'', in Streptomyces avermitilis has been achieved using a convergent approach. The stereogenic centers in two key segments were installed using Sharpless epoxidation and dihydroxylation. This synthetic study allowed the determination of the absolute configuration of avenolide as 4S,10R, and yielded important information on its structure-activity relationship.
INTRODUCTION
In several streptomycete microorganisms, g-butyrolactones have important, sometimes crucial, roles as extracellular factors in determining the onset of secondary metabolite production and morphological differentiation. Up to date, the structures of all extracellular factors are consisted of g-butyrolactones. 1,2 A-factor is required for streptomycin biosynthesis and sporulation in Streptomyces griseus 1, 2 and virginia butanolide appears to control virginiamycin biosynthesis in Streptomyces virginiae. [3] [4] [5] Other studies g-butyrolactones include IM-2 elicits production of showdomycin and minimycin in Streptomyces lavendulae FRI-5 [3] [4] [5] and SCB1 also elicits the precocious production of actinorhodin in Streptomyces coelicolor A3(2). [3] [4] [5] Genome-sequenced Streptomyces avermitilis is an important industrial microorganism for the production of anthelmintic and insecticidal macrocyclic lactone, avermectin, which is used as antiparasitic agents in the medical, veterinary and agricultural fields. To identify the extracellular factor(s) controlling avermectin production in Streptomyces avermitilis, about 1 mg of the extracellular factor from 1000 l of culture filtrate was isolated and purified by chromatographic separation steps. 6 Since spectroscopic analyses of the extracellular factor purified have elucidated that the factor is a new butenolide structure including two stereogenic centers (Scheme 1) but not gbutyrolactone structure, the extracellular factor is named as ''avenolide.'' The absolute configuration could not be elucidated, however, due to the trace quantities isolated and the presence of contaminants. Only the configuration of C4 (S, avenolide numbering) was proposed, by comparison of the CD spectra of avenolide and similar butenolide compounds. 7, 8 To undertake further biochemical properties of avenolide, the determination of the absolute structure, access to an adequate supply of avenolide and the elucidation of the structure-activity relationship are required. We describe here the first total synthesis of avenolide, which represents significant progress towards these objectives.
RESULTS AND DISCUSSION
We first embarked on the synthesis of (4S,10R)-avenolide (1) . As outlined in Scheme 1, our retrosynthetic strategy is convergent. We speculated that 1 could be derived from epoxide 2 via ring closing metathesis, which itself could be constructed by the coupling of aldehyde 3 and iodide 4. This route should provide a concise route amenable to large-scale synthesis of avenolide as well as various avenolide analogs, including stereoisomers.
The synthesis of 1 commenced with esterification of a commercially available b-methallyl alcohol with p-anisic acid (Scheme 2). Subsequent Sharpless dihydroxylation 9,10 using (DHQ) 2 PHAL as a chiral ligand afforded 5 (93% ee). [11] [12] [13] (The enantiomeric excess was determined by chiral HPLC analysis (condition: DAICEL CHIRAL-PAK AS-3 (0.46 cm fÂ25 cm), 3:1 hexanes/2-propanol mobile phase (flow rate at 1.0 ml per min) and detection at 254 nm (room temperature, rt)). Tosylation of the primary alcohol followed by a substitution reaction with Me 2 CuCNLi 2 and methanolysis gave diol 6. After acetal formation, DIBAL reduction and Parikh-Doering oxidation 14 furnished the desired aldehyde 3.
Another key intermediate 4 was derived from a commercially available 1,5-pentanediol. Mono-TBS protection, TEMPO oxidation, Wittig olefination with Ph 3 P¼CHCO 2 Et and DIBAL reduction afforded E-allyl alcohol 7. 15, 16 This was then converted to 8 by a two-step sequence of protecting group manipulations. Mesylation of the primary alcohol of 8 followed by treatment with sodium iodide gave rise to 4.
The aldehyde 3 was coupled with an alkyl lithium species derived from halogen-lithium exchange of iodide 4 with t-BuLi to furnish alcohol 9 as a diastereomeric mixture. TPAP oxidation and THP deprotection under acidic conditions afforded ketoalcohol 10. Subsequent Sharpless asymmetric epoxidation 17 using (+)-DET as a chiral ligand gave the desired epoxyalcohol 2. Transformation of the primary alcohol to iodide followed by treatment with zinc yielded the corresponding allyl alcohol, which was acylated with acryloyl chloride to provide 11. Finally, deprotection of the PMB group by treatment with DDQ and ring closing metathesis [18] [19] [20] [21] [22] using Grubbs second-generation catalyst afforded 1.
To determine the absolute configuration of 1, we also synthesized (4S,10S)-avenolide (19), according to Scheme 2, with (DHQD) 2 PHAL used instead of (DHQ) 2 PHAL as the chiral ligand in Sharpless asymmetric dihydroxylation (Scheme 3).
We next analyzed the synthetic 1 and 19 with a chiral HPLC column (conditions: DAICEL CHIRALPAK IA-3 (0.46 cm fÂ25 cm), EtOH mobile phase (flow rate of 0.3 ml per min) and detection at 200 nm (0 1C)). When a 1:1 mixture of 1 and 19 was injected onto the chiral HPLC system, the two diastereomers were completely resolved, as shown in Figure 1a . Figures 1b and c show the HPLC chromatogram of 1 and 19, respectively. An authentic sample of the natural avenolide was also analyzed by HPLC, and its retention time was identical to that of 1 as shown in Figure 1d . This result establishes the absolute configuration of avenolide as 4S,10R.
We also synthesized (4R,10R)-avenolide (22) and 10-deoxy avenolide (28) for structure-activity relationship studies as shown in Synthetic 1 demonstrated identical activity to that of natural 1. In contrast, the rAvaR1-ligand activities of the C10-epimer (19), the C4-epimer (22) and the 10-deoxy avenolide (28) demonstrated only one-half, one twenty-fifth and one hundredth of the activity of the natural product, respectively. 6 It can therefore be concluded that the stereochemistry at C4 and C10, and the presence of the hydroxyl group at C10, are important to the activity of avenolide as a rAvaR1 ligand.
In conclusion, we have achieved the total synthesis of avenolide and determined its absolute configuration. By extending the synthetic methodology, we have generated a number of structural analogs, which provide information on the structure-activity relationship of avenolide. Further biological studies on the synthetic avenolide are currently underway and will be reported in due course.
EXPERIMENTAL PROCEDURE General
IR spectra were obtained using a Horiba FT-710 spectrophotometer (Horiba, Kyoto, Japan). 1 H and 13 C-NMR spectra were obtained on Mercury-300 and UNITY-400 spectrometers (Agilent Technologies, Santa Clara, CA, USA), and chemical shifts are reported on the d scale, using TMS as an internal reference. MS spectra were measured on JEOL JMS-700, JEOL JMS-T-100LP and JEOL JMS-AX505HA spectrometers. Optical rotations were recorded on a JASCO DIP-1000 polarimeter (Jasco, Hachioji, Japan). Commercial reagents were used without further purification unless otherwise indicated. Organic solvents were distilled and dried over molecular sieves (3 or 4 Å ). Reactions were performed in flame-dried glassware under positive Ar pressure while stirring with a magnetic stirrer bar unless otherwise indicated. Flash chromatography was performed on silica gel 60N (spherical, neutral, particle size 40-50mm). TLC was performed on 0.25mm Merck silica gel 60 F254 plates (Merck, Darmstadt, Germany) and visualized by UV (254 nm), and using phosphomolybdic acid and p-anisaldehyde as TLC stains.
(R)-2,3-Dihydroxy-2-methylpropyl-4-methoxybenzoate (5) . To a solution of b-methallyl alcohol (3.50 ml, 41.3 mmol) in CH 2 Cl 2 (83 ml) were added DMAP (504 mg, 4.13 mmol), N-(3-dimethylaminopropyl)-N¢-ethylcarbodiimide hydrochloride (WSC, 8.68 g, 45.4 mmol) and p-anisic acid (6.91 g, 45.5 mmol) at rt under N 2 . The reaction mixture was stirred for 2.5 h at rt. The reaction was quenched with H 2 O and the aqueous phase was extracted with CH 2 Cl 2 . The combined organic extracts were dried over anhydrous Na 2 SO 4 and concentrated in vacuo. The residue was purified by flash column chromatography (30:1 hexanes/EtOAc) to furnish the corresponding p-methoxybenzoate (8.38 g, 99%) as a colorless oil. 4 (71.5 mg, 0.19 mmol) and (DHQ) 2 PHAL (151 mg, 0.19 mmol) at 0 1C under N 2 . The reaction mixture was stirred for 4.5 h at 0 1C. The reaction was quenched with a saturated aqueous Na 2 S 2 O 3 and the aqueous phase was extracted with CH 2 Cl 2 . The combined organic extracts were dried over anhydrous Na 2 SO 4 and concentrated in vacuo. The residue was purified by flash column chromatography (5:1 hexanes/EtOAc) to afford 5 (4.66 g, quant.) as a colorless oil. The enantiomeric excess (93% ee) of 5 was determined by chiral HPLC analysis (conditions: DAICEL CHIRALPAK AS-3 (0.46 cm fÂ25 cm), mobile phase of 3:1 hexanes/2-propanol (flow rate of 1.0 ml per min) and detection at 254 nm (rt.)).
[ To a solution of CuCN (1.79 g, 19.9 mmol) in THF (20 ml) was added MeLi (1.07 M in diethyl ether, 37.3 ml, 39.9 mmol) at À78 1C under Ar. After stirring for 20 min at 0 1C, a solution of the tosylate (1.57 g, 3.99 mmol) in THF (20 ml) was added to the reaction mixture at À78 1C. The reaction was stirred for 30 min at À78 1C, then allowed to warm to 0 1C and stirred for 20 min. The reaction was quenched with a saturated aqueous NH 4 Cl and the aqueous phase was extracted with EtOAc. The combined organic extracts were dried over anhydrous Na 2 SO 4 and concentrated in vacuo. The resulting residue was dissolved in MeOH (40 ml) and K 2 CO 3 (276 mg, 1.99 mmol) was added. After stirring for 14 h at rt, the reaction mixture was concentrated in vacuo. The residue was purified by flash column chromatography (5:1 hexanes/EtOAc) to give 6 (373 mg, 90% over 2 steps) as a colorless oil.
[ (R)-2-((4-Methoxybenzyl)oxy)-2-methylbutanal (3). To a solution of 6 (776 mg, 7.46 mmol) in CH 2 Cl 2 (30 ml) were added PPTS (93.7 mg, 0.37 mmol) and panisaldehyde dimethylacetal (1.27 ml, 7.46 mmol) at rt under N 2 . The reaction mixture was stirred for 6 h at rt. The reaction was quenched with H 2 O and the aqueous phase was extracted with EtOAc. The combined organic extracts were Scheme 4 Reagents and conditions: the same reaction conditions as those described in Scheme 2 were used unless otherwise noted. (z) (À)-DET, Ti(Oi-Pr) 4 To a solution of the p-methoxybenzylidene acetal (697 mg, 3.14 mmol) in CH 2 Cl 2 (31 ml) was added DIBAL (1.02 M in hexanes, 9.00 ml, 9.41 mmol) at 0 1C under N 2 . After stirring for 1 h at 0 1C, the reaction was cautiously quenched with MeOH, diluted with CH 2 Cl 2 and treated with celite (2.80 g) and Na 2 SO 4 Á10H 2 O (2.80 g). The mixture was allowed to warm to rt and stirred for 2 h. It was then filtered through a pad of celite and the filtrate was concentrated. The residue was purified by flash column chromatography (10:1 hexanes/ EtOAc) to give the corresponding alcohol (615 mg, 87%) as a colorless oil.
[ To a solution of the alcohol (239 mg, 0.94 mmol) in CH 2 Cl 2 (9.4 ml) were added DMSO (666 ml, 9.37 mmol), Et 3 N (1.31 ml, 9.37 mmol) and SO 3 Ápyr (895 mg, 5.62 mmol) at rt under N 2 . The reaction mixture was stirred for 3.5 h at rt. The reaction was quenched with H 2 O and the aqueous phase was extracted with CH 2 Cl 2 . The combined organic extracts were dried over anhydrous Na 2 SO 4 and concentrated in vacuo. The residue was purified by flash column chromatography (50:1 hexanes/EtOAc) to furnish 3 (188 mg, 89%) as a colorless oil.
[ (E)-7-((tert-Butyldimethylsilyl)oxy)hept-2-en-1-ol (7) . To a solution of NaH (1.94 g, 47.5 mmol) in THF (158 ml) were added 1,5-pentanediol (5.00 ml, 47.5 mmol) and TBSCl (7.31 g, 47.5 mmol) at 0 1C under N 2 . The reaction mixture was stirred for 5 min at 0 1C, then allowed to warm to rt and stirred for 2.5 h. The reaction was quenched with H 2 O at 0 1C and the aqueous phase was extracted with CH 2 Cl 2 . The combined organic extracts were dried over anhydrous Na 2 SO 4 and concentrated in vacuo. To a solution of the TBS ether (4.00 g, 18.3 mmol) in CH 2 Cl 2 (183 ml) were added iodobenzene diacetate (8.86 g, 27.5 mmol) and TEMPO (573 mg, 3.67 mmol) at rt under N 2 . The reaction mixture was stirred for 5 h at rt. The reaction was quenched with an aqueous Na 2 S 2 O 3 solution, and the aqueous phase was extracted with CH 2 Cl 2 . The combined organic extracts were dried over anhydrous Na 2 SO 4 and concentrated in vacuo. The residue was purified by flash column chromatography (50:1 hexanes/EtOAc) to afford the corresponding aldehyde (3.96 g, quant.) as a colorless oil.
IR ( CDCl 3 ) d 166.7, 149.1, 121.4, 62.7, 60.1, 32.2, 31.9,  25.9, 24.4, 18.3, 14. 3, -5.32; HRMS (ESI + , TFA-Na) calcd for C 15 To a solution of the THP ether (2.11 g, 6.42 mmol) in THF (64 ml) was added TBAF (7.71 ml, 7.71 mmol) at rt under N 2 . The reaction mixture was stirred for 4.5 h at rt. The reaction was quenched with H 2 O, and the aqueous phase was extracted with CH 2 Cl 2 . The combined organic extracts were dried over anhydrous Na 2 SO 4 and concentrated in vacuo. (E)-2-((7-Iodohept-2-en-1-yl)oxy)tetrahydro-2H-pyran (4). To a solution of 8 (657 mg, 3.07 mmol) in CH 2 Cl 2 (31 ml) were added Et 3 N (855 ml, 6.14 mmol), Me 3 NÁHCl (29.3 mg, 0.31 mmol) and MsCl (356 ml, 4.61 mmol) at 0 1C under N 2 . The reaction mixture was allowed to warm to rt and stirred for 3 h. The reaction was quenched with H 2 O and the aqueous phase was extracted with CH 2 Cl 2 . The combined organic extracts were dried over anhydrous Na 2 SO 4 and concentrated in vacuo. The residue was purified by flash column chromatography (10:1 hexanes/EtOAc) to afford the corresponding mesylate (837 mg, 93%) as a colorless oil.
IR (3R,E)-3-((4-Methoxybenzyl)oxy)-3-methyl-11-((tetrahydro-2H-pyran-2-yl)oxy)un dec-9-en-4-ol (9) . To a solution of iodide 4 (844 mg, 3.8 mmol) in pentane (22 ml) were added Et 2 O (8.2ml) and t-BuLi (1.55 M in pentane, 5.64 ml, 8.74 mmol) at À78 1C under Ar. After stirring for 15 min at À78 1C, a solution of aldehyde 3 (1.35 g, 4.18 mmol) in Et 2 O (7.0 ml) was added. The reaction mixture was allowed to warm to 0 1C and stirred for 3 h. The mixture was quenched with an aqueous NH 4 Cl solution and the aqueous phase was extracted with EtOAc. The combined organic extracts were dried over anhydrous Na 2 SO 4 and concentrated in vacuo. The residue was purified by flash column chromatography (15:1 hexanes/EtOAc) to afford 9 (1.54 g, 96%) as a colorless oil.
[ (R,E)-11-Hydroxy-3-((4-methoxybenzyl)oxy)-3-methylundec-9-en-4-one (10) . To a solution of 9 (674 mg, 1.60 mmol) in CH 2 Cl 2 (16 ml) were added NMO (380 mg, 3.21 mmol), TPAP (28.2 mg, 0.08 mmol) and 4 Å molecular sieves (674 mg) at rt under N 2 . The reaction mixture was stirred for 1.5 h at rt. The mixture was filtered through a pad of celite. The filtrate was diluted with H 2 O and extracted with CH 2 Cl 2 followed by EtOAc. The combined organic extracts were dried over anhydrous Na 2 SO 4 and concentrated in vacuo. The residue was purified by flash column chromatography (40:1 hexanes/ EtOAc) to afford the corresponding ketone (652 mg, 97%) as a colorless oil.
[a] 27 D +7. To a solution of the ketone (597 mg, 1.43 mmol) in MeOH (14 ml) was added PPTS (359 mg, 1.43 mmol) at rt under N 2 . The reaction mixture was stirred for 5 h at rt. The reaction was quenched with H 2 O and the aqueous phase was extracted with CH 2 Cl 2 . The combined organic extracts were dried over anhydrous Na 2 SO 4 and concentrated in vacuo. The residue was purified by flash column chromatography (10:1 hexanes/EtOAc) to afford 10 (475 mg, 99%) as a colorless oil.
[ 
